-The phenotype conversion of fibroblasts to myofibroblasts plays a key role in the pathogenesis of cardiac fibrosis. Numerous triggers of this conversion process have been identified, including plating of cells on solid substrates, cytokines such as transforming growth factor-␤, and mechanical stretch; however, the underlying mechanisms remain incompletely defined. Recent studies from our laboratory revealed that the transcription factor scleraxis is a key regulator of cardiac fibroblast phenotype and extracellular matrix expression. Here we report that mechanical stretch induces type I collagen expression and morphological changes indicative of cardiac myofibroblast conversion, as well as scleraxis expression via activation of the scleraxis promoter. Scleraxis causes phenotypic changes similar to stretch, and the effect of stretch is attenuated in scleraxis null cells. Scleraxis was also sufficient to upregulate expression of vinculin and F-actin, to induce stress fiber and focal adhesion formation, and to attenuate both cell migration and proliferation, further evidence of scleraxis-mediated regulation of fibroblast to myofibroblast conversion. Together, these data confirm that scleraxis is sufficient to promote the myofibroblast phenotype and is a required effector of stretch-mediated conversion. Scleraxis may thus represent a potential target for the development of novel antifibrotic therapies aimed at inhibiting myofibroblast formation. transcription factor; cardiac fibroblast; stretch; migration; proliferation MYOFIBROBLASTS, AS THE ACTIVATED form of fibroblasts, are major mediators of tissue fibrosis in the heart, lungs, dermis, kidneys, and gastrointestinal tract (17, 26, 29, 36, 42) . Excess deposition of fibrillar collagens in the extracellular matrix (ECM) of these tissues imparts increased stiffness and reduced organ function. Cardiac fibrosis entails a poor prognosis, negatively impacting both systolic and diastolic function and eventually leading to heart failure and death (43). There currently exists no treatment for the arrest or reversal of cardiac fibrosis (38). However, alteration of the myofibroblast phenotype may provide a novel means for the treatment and even reversal of fibrotic lesions in various tissue types (20, 21, 23, 26, 34, 37, 49) .
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In response to myocardial injury, the release of damage factors [such as profibrotic transforming growth factor-␤ (TGF-␤)] and mechanical strain resulting from the loss of ECM integrity induce activation of cardiac fibroblasts and subsequent conversion to the myofibroblast phenotype (11, 14, 22, 25, 32) . Cardiac myofibroblasts are characterized by hypersynthesis of fibrillar collagens type I and III, increased expression of ␣-smooth muscle actin (␣-SMA), increased adhesions and cell size, reduced proliferation and migration, and the formation of stress fibers (12, 18, 39, 44, 46) . The morphological and functional changes that cardiac fibroblasts undergo during their conversion to myofibroblasts are critical to the wound healing process following myocardial injury. The localization of myofibroblasts in the infarct region and their contribution of collagen to scar formation require a decrease in their migration and proliferation, as well as increased adhesion to the surrounding matrix. Stress fibers formed during the conversion of fibroblasts to myofibroblasts impart contractility to these cells, a necessary function of scar formation and maturation (44) .
The transcription factor scleraxis is necessary for proper ECM composition in collagen-rich tissues including tendons and heart valves (4, 5, 31) . Mechanical stretch of tendons, tenocytes, and mesenchymal stem cells increases expression of scleraxis, as well as type I and III collagens (9, 40, 41, 48) . Mechanical stretch of cardiac fibroblasts induces increased expression of type I and III collagens, possibly via a mechanism that requires protein kinase C or tyrosine kinase activity, but the effect on scleraxis expression was not determined (6, 8, 28) .
We previously reported a significant increase in scleraxis in the infarct scar of rat hearts 4 wk post-myocardial infarction. This increase in scleraxis is concomitant with increased levels of fibrillar collagens, ostensibly due to direct transactivation of the collagen I␣2 promoter (1, 16) . Studies by our laboratory in primary rat cardiac fibroblasts have shown that scleraxis expression is increased with TGF-␤ treatment, as well as during conversion to the myofibroblast phenotype induced by cell passaging, which has been shown to involve an intermediate phenotype termed the proto-myofibroblast (1, 25, 44) . Most recently, we have demonstrated that scleraxis is both sufficient and required for fibroblast to myofibroblast phenotype conversion in response to TGF-␤ and that scleraxis regulates fibro-blast number in the heart (3). Here we have extended these studies to determine the effect of cyclical mechanical stretch on myofibroblast characteristics and scleraxis expression in cardiac proto-myofibroblasts, as well as the effect of scleraxis expression on myofibroblast functions (stress fiber formation, migration, cell cycle progression, and proliferation). We found that mechanical stretch and scleraxis induce similar phenotypic changes in primary cardiac proto-myofibroblasts indicative of conversion to myofibroblasts. Furthermore, stretch induces scleraxis expression, and scleraxis is required for stretch to induce the phenotypic changes indicative of phenotype conversion, demonstrating that scleraxis plays a key role in stretch-mediated conversion of cardiac fibroblasts to myofibroblasts.
MATERIALS AND METHODS
Cell culture and treatments. Primary cardiac fibroblasts were isolated from adult male Sprague-Dawley rats using enzymatic digestion as described previously (1, 16) . Freshly isolated cardiac fibroblasts (P0) were used 72 h postisolation or passaged to proto-myofibroblasts (P1) or myofibroblasts (P2) for experiments. Cells were synchronized in serum-free DME/F12 medium including 0.1% ascorbic acid and 1% penicillin/streptomycin (GIBCO) for 24 h before infection with adenoviral constructs. P1 and P2 cells were infected with adenovirus encoding green fluorescent protein (GFP) (AdGFP) or Scx (AdScx) for 24 h at multiplicity of infection (MOI) 10 or with adenoviral constructs encoding short-hairpin RNA for LacZ (AdshLacZ) or scleraxis (AdshScx) for 48 h at MOI 200; we routinely obtain infection efficiency Ͼ90% using this approach and amplified and titered adenoviruses as previously reported (1, 3, 16) . Isolation of primary cardiac fibroblasts from scleraxis knockout mice or C57BL6 wild-type controls was as previously described (3) . Animals were handled according to the guidelines of the Canadian Council on Animal Care; animal usage was approved by the Animal Care Committee of the University of Manitoba.
Luciferase assay. NIH-3T3 fibroblasts (ATCC) were transfected with the 1,500 bp-scleraxis proximal promoter (250 ng) (pGL4.10-SCX1500; GeneCopoeia) for 24 h and subjected to cyclic stretch (see below). Five nanograms of Renilla expression vector were used as transfection control. Transfections were performed with Lipofectamine 2000 (3:1) and Opti-MEM (Life Technologies). Luciferase activity of each sample was assayed using a Dual-Luciferase Reporter Assay System (Promega) as per manufacturer's instructions on a Glomax Multiϩ Detection System (Promega).
Immunofluorescence staining. Primary cardiac proto-myofibroblasts were plated on glass coverslips, serum-starved for 24 h, and infected with adenovirus encoding LacZ (AdLacZ) or Scx (AdSCX) for 48 h at MOI 10. Cells were washed with sterile 1ϫ PBS, fixed in 4% paraformaldehyde, permeabilized (0.5% Triton-X), and probed using the FAK100 Actin Cytoskeleton/Focal Adhesion Staining Kit (Millipore), as per manufacturer instructions. Images were acquired on a Zeiss AxioImager M1 epifluorescence microscope with a ϫ40 or ϫ63 oil immersion objective. Manipulations of color channel output levels or brightness/contrast in Adobe Photoshop CS6 were performed identically between AdLacZ and AdScx images.
Western blotting. Total cellular protein was extracted as previously described (1, 16) . Protein samples were resolved via SDS-PAGE and transferred to polyvinylidene fluoride (PVDF) membrane (EMD Millipore). Membranes were probed with specific antibodies for anti-␣-tubulin (DSHB), anti-type I collagen (Cedarlane), anti-focal adhesion kinase, anti-Y397 phosphorylated focal adhesion kinase (BioSource International), anti-integrin ␤1/CD29 (Chemicon; EMD Millipore), anti-PCNA (Novex; Thermo Fisher Scientific), or anti-scleraxis (1, 16) . Antibodies were detected using Western Blotting Luminol Reagent (Santa Cruz Biotechnology) and visualized with CL-Xposure blue X-ray film (Thermo Fisher Scientific). Protein expression was quantified with QuantityOne software (Bio-Rad) and normalized to ␣-tubulin (loading control).
Quantitative real-time polymerase chain reaction. Total RNA was isolated using a GeneJET RNA Purification Kit (Thermo Fisher Scientific). One-step quantitative (q)PCR analysis was performed on a Bio-Rad iQ5 iCycler using SYBR Green-based reagents (Quanta Biosciences). Twenty-five nanograms RNA template were used for all reactions with specific primers for gene targets (Table 1) . Gene expression was calculated using the 2 Ϫ⌬⌬CT method and normalized to GAPDH.
Cyclic stretch assay. Untreated flexible silicone elastomer membranes in six-well plate format (FlexCell) were precoated with 100 ng/l human plasma fibronectin (EMD Millipore). Cells were seeded using 10% FBS-supplemented media and allowed to attach for 24 h, followed by serum starvation for 24 h. Mouse cells were treated similarly to rat cells, but were instead plated on 1 g/ml pronectin (FlexCell) and maintained in 1% FBS-supplemented media. With the use of a FlexCentral FX-4000 FlexerCell Strain Unit (FlexCell), a program of cyclic (1 Hz) equibiaxial stretch of 10 or 15% elongation was applied to stretch plates for 24 or 48 h; conversely, no elongation was applied in the same apparatus for nonstretched controls. Total cellular protein and RNA were isolated and subjected to Western blotting and qPCR, respectively.
Transwell migration assay. Cells were seeded on sterile polycarbonate membrane inserts (24 mm, 8 .0 m pore; Corning Life Sciences) and allowed to attach for 24 h. Following serum starvation for 24 h, cells were infected with overexpression or knockdown adenovirus or were uninfected (control). At time 0, 10 ng/ml plateletderived growth factor-BB was added to the lower chamber of all wells. Serum-free media were added to the upper chambers to establish a chemoattractant gradient. After 24 h, lower chambers were washed and fixed with 4% paraformaldehyde. Cells were stained with 5% crystal violet, and the number of migrated cells was determined by manual counting of stained cells in a minimum of five fields/well at total magnification of ϫ400 and multiplied by the area factor for each field to represent the total number of cells per well.
Wound healing assay. Primary rat cardiac P1 proto-myofibroblasts seeded in six-well tissue culture-treated dishes were infected with either AdshLacZ or AdshScx adenovirus at 200 MOI for 48 h, or either AdGFP or AdScx adenovirus at 10 MOI for 24 h, or were uninfected (control). A dashed line was made on the underside of each well and a scratch introduced over this line using a P200 pipette tip. Cells were then treated with serum-free medium. Images of initial 
Primers are specific for both rat and mouse transcripts.
wounds (0 h) and wounded area 24 h later were captured using a Nixon CoolPix 995 digital camera with a ϫ40 objective on an inverted microscope. Fluorescence-activated cell sorting analysis. Freshly isolated fibroblasts (P0), proto-myofibroblasts (P1), and myofibroblasts (P2) were incubated with 5-ethynyl-2=-deoxyuridine (EdU)-supplemented media for 2 h and processed for cell cycle analysis using flow cytometry and commercially available reagents (Life Technologies). Cells were fixed and permeabilized using saponin-based reagent (Life Technologies). Nuclei were stained using propidium iodide (Life Technologies, Canada) containing 0.5 mg/ml RNase A (Invitrogen) to eliminate double-stranded RNA. Data were collected using a FACSCanto flow cytometer (Becton Dickinson) and analyzed using FlowJo software.
Proliferation assay. Primary rat cardiac proto-myofibroblasts were serum starved for 24 h and then infected with AdScx or AdLacZ (control) adenoviral constructs for 24 h followed by incubation in serum-supplemented media with 10 M EdU for another 24 h. Cells were then fixed (3.7% formaldehyde), permeabilized (0.5% Triton-X), and EdU label was detected using a commercially available kit as per manufacturer's instructions (Life Technologies). Hoechst 33342 was used to stain nuclei. Images were acquired on a Zeiss epifluorescence microscope with a ϫ20 objective (Zeiss). The percentage of EdU ϩ cells/total cells was counted from three to four fields for each sample and calculated to represent percent cell proliferation.
Statistical analysis. Experiments were repeated with a minimum of three independent biological replicates (n ϭ 3), such that each replicate was produced from a different rat or mouse (for primary cells). Data were analyzed by Student's t-test or one-way ANOVA with Student-Newman-Keuls post hoc analysis. Results with P Ͻ 0.05 were considered statistically significant.
RESULTS

Mechanical stretch induces expression of fibrillar collagens
and the myofibroblast marker ␣-SMA. Mechanical stretch has previously been reported to promote the development of myofibroblast characteristics such as increased collagen expression and stress fiber remodeling (6, 8, 27, 28, 47) . To confirm a similar effect in the heart, primary rat cardiac proto-myofibroblasts were exposed to 24 h of cyclic, equibiaxial stretch (15% elongation, 1 Hz frequency) on fibronectin-coated flexible silicon membranes. mRNA levels of fibrillar collagens I and III and the myofibroblast marker ␣-SMA were assessed by quantitative real-time PCR. In response to stretch, mRNA levels of both type I collagen isoforms (␣1 and ␣2) and collagen 3␣1 were significantly increased compared with nonstretched but identically plated control proto-myofibroblasts (Fig. 1A ). In addition, the level of ␣-SMA mRNA was dramatically increased by stretch more than fivefold (Fig. 1B) . Similarly, Western blotting revealed a significant increase in both the 70-and 130-kDa isoforms of type I collagen (Fig. 1C) . These gene expression changes are consistent with phenotype conversion to myofibroblasts.
Scleraxis promotes cardiac proto-myofibroblast phenotype conversion. To determine whether scleraxis was able to induce phenotype changes similar to mechanical stretch, we infected primary cardiac proto-myofibroblasts with a scleraxis-encoding adenoviral vector (AdScx) to ensure high efficiency transfection (Fig. 2, A and B) (1, 16) . Compared with infection with GFP-encoding control adenovirus (AdGFP), infection with AdScx strongly induced collagen I protein expression, similar to the effect of stretch but at even greater relative levels (Fig. 2C) .
Scleraxis expression is induced by mechanical stretch. Since stretch and scleraxis overexpression exerted similar effects on myofibroblast collagen expression, we tested whether stretch was capable of inducing scleraxis expression. Using an identical protocol as employed in Fig. 1 (15% stretch for 24 h, 1 Hz), we observed that compared with nonstretched controls, mechanical stretch significantly increased levels of scleraxis mRNA more than threefold (Fig. 3A) . Stretch similarly induced scleraxis protein expression (Fig. 3B) . It is unclear whether these alterations represent activation of scleraxis transcription, or changes in the stability of scleraxis mRNA and/or protein. We therefore assayed the effect of stretch on transactivation of the proximal 1,500 bp of the human scleraxis promoter via luciferase reporter assay in NIH-3T3 fibroblasts. Compared with nonstretched controls, scleraxis promoter reporter gene activity was significantly increased by stretch more than threefold (Fig. 3C ), indicating that increased scleraxis levels following stretch are due primarily to gene transactivation. To investigate the effect of altered stretch conditions, we subjected primary cardiac proto-myofibroblasts to 0% (nonstretched control), 10, or 15% stretch for 24 h; additionally, we subjected cells to 15% stretch for 48 h. While 15% stretch for 24 h resulted in a significant induction of both scleraxis and collagen 1␣1 mRNA, reduced stretch of 10% failed to induce either gene (Fig. 3, D and E) . Increasing the time of stretch to 48 h had no effect on scleraxis levels but caused a slight yet significant reduction in collagen 1␣1 mRNA. These results indicated that our selected parameters of 15% stretch for 24 h were optimal for our studies; these conditions were used for all subsequent experiments.
Mechanical stretch alters cardiac proto-myofibroblast morphology. To further investigate the effect of stretch on myofibroblast phenotype, cell morphology was examined following crystal violet staining. Compared with nonstretched control cardiac proto-myofibroblasts, cells exposed to 24 h of stretch consistently appeared to be less numerous, and individual cell area was increased significantly (Fig. 4A) . Compared with fibroblasts, myofibroblasts exhibit decreased turnover of adhesions, a process driven by the phosphorylation and activation of focal adhesion kinase (FAK) (35, 39) . We observed decreased FAK phosphorylation at a key tyrosine residue indicative of FAK activation, Y397 (normalized to total FAK protein) in response to cyclic stretch of cardiac proto-myofibroblasts (Fig. 4B) . This reduction in FAK Y397 phosphorylation and activation is consistent with increased focal adhesion stability and greater attachment of cells to their underlying substratum, resulting in cell spreading, an effect congruent with the increase in cell size observed following stretch (Fig. 4A) .
Intriguingly, the stretch-mediated increase in cell size was dramatically attenuated in cardiac proto-myofibroblasts isolated from scleraxis knockout mice (Fig. 4C) , suggesting that these cells failed to undergo stretch-induced phenotype conversion. Unstretched scleraxis knockout cells were significantly smaller than wild-type cells, and a 90% relative increase in cell size in response to stretch in wild-type cells was reduced to a ϳ27% increase in scleraxis knockout cells. To confirm this result, we assayed mRNA levels of collagen 1␣1 and ␣-SMA, which are both induced by phenotype conversion to myofibroblasts. In wild-type mouse proto-myofibroblasts, stretch significantly upregulated both markers as anticipated (Fig. 4D) . In stark contrast, not only were collagen 1␣1 and ␣-SMA mRNA levels reduced in scleraxis null cells in agreement with our recently published data (3), but stretch failed to increase mRNA levels of these markers. Together, these results demonstrate that scleraxis is required for stretchinduced phenotype conversion to myofibroblasts.
Scleraxis alters adhesion and migration of cardiac proto-myofibroblasts. Decreased focal adhesion turnover in myofibroblasts concomitant with the increased presence of filamentous F-actin is indicative of increased cell-substrate adhesion (7). Phalloidin staining of cardiac proto-myofibroblasts revealed a striking increase in F-actin expression and fiber density following scleraxis overexpression compared with LacZ-infected controls (Fig. 5A) . Concomitantly, there were dramatic increases in both general vinculin staining and the presence of peripherally located vinculin-positive focal adhesions (Fig. 5B) , indicative of increased stable focal adhesion formation.
Increased adhesion reduces cell migration; thus we assayed the effect of scleraxis on cardiac proto-myofibroblast migration via two independent approaches. Using a wound-healing scratch assay, we observed that fewer scleraxis-infected cells migrated into the cell-denuded region at 24 h postwounding of the cell monolayer, compared with either noninfected or GFP-infected controls (Fig. 5C ). In contrast, scleraxis shRNA-mediated knockdown promoted cell migration into the wound compared with a control shRNA targeting LacZ (Fig. 5C ). These results were confirmed using a modified Boyden chamber Transwell migration assay, which employed platelet-derived growth factor-BB as a chemoattractant. Scleraxis overexpression reduced cell migration by more than half (Fig. 5D) . Conversely, scleraxis knockdown significantly increased the number of migrated cells after 24 h by more than 50% (Fig. 5D) . Scleraxis overexpression also resulted in a significant increase in the expression of integrin-␤1, which contributes to the structure of stable focal adhesions (Fig. 5E) , similar to the increase in integrin-␤1 expression induced by cell stretch (Fig. 5F ). Together, these results indicate that scleraxis overexpression promotes focal adhesion formation and stabilization and increased cell adhesion to the substratum, which in turn reduces cell migration congruent with the transition to myofibroblasts (39) .
Scleraxis reduces cell cycle progression. Previous studies have shown that myofibroblasts are less proliferative than fibroblasts (46) . Sequential passaging on standard stiff plastic tissue culture plates promotes fibroblast to myofibroblast conversion (15, 39). Freshly isolated (P0) cardiac fibroblasts, first passage (P1) proto-myofibroblasts, and second passage (P2) myofibroblasts were therefore labeled with propidium iodide and analyzed via flow cytometry to assess the proportion of cells in various stages of the cell cycle. With fibroblast to myofibroblast phenotype conversion, we observed an increase in the absolute number of cells in the G 0 /G 1 phase, a reduction in cells in S phase, and an increase in the number of cells in the G 2 /M phase, indicating that cells are progressively exiting the cell cycle (Fig. 6A) . Normalized to total cell counts, the proportion of cells in these phases changed similarly during fibroblast to myofibroblast transition (Fig. 6B) , confirming a decreased number of cycling cells.
Since scleraxis, like cell passaging, promotes fibroblast to myofibroblast transition, we determined whether scleraxis exerted a similar inhibitory effect on cell proliferation. Scleraxis overexpression in cardiac proto-myofibroblasts resulted in a reduction of EdU labeling, indicating reduced proliferation (Fig. 6, C and D) . Similarly, scleraxis also induced cardiac proto-myofibroblasts to exit the cell cycle as determined using flow cytometry (Fig. 6E) . Indeed, cells overexpressing scleraxis exhibited a similar profile of relative cell numbers in G 0 /G 1 , S, and G 2 /M phases as P2 myofibroblasts (Fig. 6, B and  F) . We confirmed these results by assaying proliferating cell nuclear antigen (PCNA) protein expression. PCNA expression decreased significantly with passage number as P0 fibroblasts progressed to P2 myofibroblasts (Fig. 6G ). Both cell stretch (Fig. 6H) and overexpression of scleraxis (Fig. 6I ) similarly reduced PCNA expression in proto-myofibroblasts to nearly the degree observed in P2 myofibroblasts. Scleraxis thus appears to be sufficient to cause cell cycle exit and reduced proliferation of cardiac proto-myofibroblasts.
DISCUSSION
Although cardiac myofibroblasts are critical for deposition of a collagen-rich matrix following myocardial infarction, their persistence in the noninfarcted and distal regions of the myocardium is the basis for cardiac fibrosis (38) . Although many factors have been shown to be involved in the conversion of cardiac fibroblasts to myofibroblasts, many of these (such as TGF-␤) are pleiotropic molecules that represent poor choices for therapeutic targets. We recently demonstrated that scleraxis is sufficient to induce epithelial-to-mesenchymal transition and is required for fibroblast to myofibroblast phenotype conversion induced by TGF-␤, suggesting that scleraxis is a key cell phenotype regulator in these cells (3) . Here we show that scleraxis is a critical regulator of the cardiac myofibroblast phenotype in response to mechanical stretch, consistent with such a role.
In vitro and in vivo studies have demonstrated the ability of mechanical tension to drive the conversion of fibroblasts to myofibroblasts (24) . Here, we confirm these findings in cardiac proto-myofibroblasts, an intermediate and plastic cell type in what has been described as a continuum of cell conversion (19) . Due to its intermediate nature and responsiveness to different stimuli, the proto-myofibroblast provides an ideal setting for examining phenotypic changes both in the forward direction (towards the myofibroblast phenotype) as well as the reverse (towards the fibroblast phenotype). Phenotype conversion of stretched cardiac proto-myofibroblasts is indicated by increased levels of key myofibroblast markers (fibrillar collagens and ␣-SMA; Fig. 1 ), concomitant with increased scleraxis production (Fig. 3) , and morphological changes that are char- primary rat cardiac proto-myofibroblasts were subjected to 15% equibiaxial stretch (1 Hz) for 24 h as in Fig.  1 . Levels of scleraxis mRNA (A) and protein (B) were assessed by qPCR and Western blotting, respectively. ␣-tubulin loading control was the same as in Fig. 1C . C: NIH-3T3 fibroblasts were transfected with a scleraxis promoter luciferase reporter vector and subjected to equibiaxial stretch or were nonstretched (control) and were assayed for reporter expression. Results were normalized to GAPDH (A), ␣-tubulin (B), or cotransfected Renilla luciferase (C) and to control; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. control. D and E: cardiac proto-myofibroblasts were subjected to 10 or 15% equibiaxial stretch (1 Hz) or were not stretched (0%) for 24 or 48 h. mRNA encoding scleraxis (D) or collagen 1␣1 (E) was assayed by qPCR and normalized to GADPH and to nonstretched controls; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. 0%; #P Ͻ 0.05 vs. corresponding 24-h time point.
acteristic of the myofibroblast phenotype, i.e., increased cell size and spreading (Fig. 4A) . Importantly, these phenotypic changes in response to stretch were critically dependent on scleraxis function, as scleraxis null cells were significantly smaller than wild-type, exhibited attenuated cell size changes in response to stretch, and failed to upregulate collagen 1␣1 and ␣-SMA in response to stretch (Fig. 4, B and C) , indicating that myofibroblast conversion was impaired. Although previous studies have demonstrated increased scleraxis expression in several cell types in response to cyclic stretch, we are the first to show that this phenomenon occurs in cardiac fibroblasts (Fig. 3 ). Our results demonstrate that scleraxis is necessary for stretch-induced cardiac myofibroblast characteristics (Fig. 7) . This notion is further supported by the finding that scleraxis expression itself is able to drive a significant increase in levels of type I collagen (Fig. 2C) , far greater than that observed in response to stretch (Fig. 1, A and C ) and in agreement with data from our laboratory and others that type I collagen is upregulated by scleraxis (1, 16, 30) . Increased activity of the 1,500-bp scleraxis proximal promoter reporter gene in response to stretch indicates that this promoter may potentially act as an integrator of upstream signals to mediate stretch-induced cardiac myofibroblast phenotype conversion. We have expanded on the existing literature that reported a transient increase in FAK phosphorylation at tyrosine 397 in response to cyclic stretch followed by a decline after 6 h (13). We demonstrate here for the first time significant downregulation of tyrosine 397 phosphorylation in response to 24 h of cyclic stretch: a phenomenon implicated in both decreased focal adhesion turnover and increased cell adhesion, additional hallmarks of the conversion to the myofibroblast phenotype (10) .
Our study utilized both gain-and loss-of-function experiments to demonstrate the necessity of scleraxis in regulating additional key characteristics of the cardiac myofibroblast phenotype. The conversion of myofibroblasts is marked by an Fig. 4 . Stretch-induced myofibroblast morphology requires scleraxis. A: cardiac proto-myofibroblasts were subjected to 15% equibiaxial stretch (1 Hz), or were nonstretched, as in Fig. 1 , then stained with crystal violet. Magnification: ϫ100 (top; scale bar ϭ 100 m) or ϫ200 (bottom; scale bar ϭ 100 m). Average cell area was measured, with results normalized to control (unstretched) cells; mean Ϯ SE; n ϭ 3 (68 -151 cells per group, 5-10 fields); *P Ͻ 0.05 vs. control. B: cardiac proto-myofibroblasts subjected to stretch as in A were assessed for expression of Y397-phosphorylated FAK (top). Results were normalized to total FAK and nonstretched controls; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. control cells. C: control or stretched (15%, 1 Hz, 24 h) cardiac proto-myofibroblasts from wild-type (WT) or scleraxis null (KO) mice were stained with crystal violet and visualized. Magnification: ϫ200; scale bar ϭ 100 m. Average cell area was measured, with results normalized to control (unstretched) WT cells; mean Ϯ SE; n ϭ 3 (51-84 cells per group, 5-11 fields); *P Ͻ 0.05 vs. control; #P Ͻ 0.05 vs. WT. D: control or stretched cardiac proto-myofibroblasts from WT or KO mice were assayed by qPCR for mRNA levels of collagen 1␣1 and ␣-SMA. Results were normalized to GADPH and control WT cells; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. control; #P Ͻ 0.05 vs. WT. primary cardiac proto-myofibroblasts were infected with adenoviruses as in C and then subject to Transwell migration assay. The number of cells migrated in 24 h was assessed; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. control or AdGFP (AdScx) or vs. control or AdshLacZ (AdshScx). E and F: integrin ␤1 expression was assayed in primary cardiac proto-myofibroblasts infected with AdGFP or AdScx (E) or subjected to 15% equibiaxial stretch (1 Hz) for 24 h vs. unstretched controls (F), and normalized to ␣-tubulin and either AdGFP or unstretched controls; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. AdGFP or control. Note: the loading control shown in F is the same as in Fig. 6H as the blot was reprobed. increase in cell adhesion, which is attributed to increased size and strength of focal adhesions and associated actin fibers, which mature into larger, thicker stress fibers. Colocalization of focal adhesion proteins such as vinculin at adhesion sites promotes further recruitment of focal adhesion components, as well as association with the intracellular actin cytoskeleton (27) . Contractility is an important hallmark that differentiates myofibroblasts from fibroblasts, facilitating wound closure and preventing cardiac rupture; this ability is imparted by the polymerization of actin monomers into filamentous actin (F-actin) stress fibers (45) . Indeed, with scleraxis overexpression, proto-myofibroblasts exhibit a dramatic increase in phalloidin staining of F-actin (Fig. 5A) as well as upregulation of vinculin with increased vinculin localization to focal adhesions, indicative of reduced focal adhesion turnover and stabilized substratum attachment (Fig. 5B ) and in agreement with the finding that both stretch and scleraxis upregulate integrin-␤1 expression (Fig. 5, E and F) . Since myofibroblasts must remain in the infarcted region for the deposition of collagen and wound contracture, migration is also decreased during phenoconversion (46) . Given our report of increased focal adhesion stabilization, it is not surprising that scleraxis overexpression in cardiac proto-myofibroblasts significantly reduced migration, a finding congruent with increased cell attachment. Interestingly, knock-down of scleraxis expression significantly increased the migratory capability of these cells (Fig. 5, C and D) . These novel results reveal that scleraxis is a bona fide regulator of the migratory ability of these cells and speak to the utility of proto-myofibroblasts in examining the forward and reverse processes of phenoconversion.
In addition to being more synthetic, more adhesive, and less migratory, myofibroblasts are also less proliferative; this function is primarily required in the very early stages of the response to cardiac injury, wherein fibroblasts are activated and recruited to the damage site. Once established in the wounded area, however, the need for myofibroblast migration and proliferation decreases, and the primary function of myofibroblasts is to produce ECM to replace dead cardiomyocytes and necrotic tissue (33) . We demonstrate that, in fact, conversion of freshly isolated (P0) cardiac fibroblasts, through the first passage (P1) proto-myofibroblast phenotype to the second passage (P2) myofibroblast phenotype, is marked by a reduction of the total number of cells in the synthetic and repair phases of the cell cycle (S and G 2 M; Fig. 6, A and B) . In keeping with our findings that scleraxis drives the conversion to the myofibroblast phenotype, overexpression of scleraxis in proto-myofibroblasts both significantly reduces proliferation, indicated by a reduction in the number of EdU-positive cells (Fig. 6D ) and decreased PCNA expression (Fig. 6I) , and reduces the total number of cells in the synthetic and repair phases of the cell cycle (Fig. 6, E and F) .
A key outstanding question is the delineation of exactly how scleraxis exerts its myriad effects on focal adhesion formation, migration, and proliferation. Our previous studies have greatly expanded on the number of direct target genes of scleraxis, demonstrating direct transcriptional regulation of collagen 1␣2, ␣-SMA, Snai1, Twist1, and fibronectin (2, 3) . It is possible that scleraxis similarly directly regulates genes encoding integrin-␤1 and vinculin and perhaps even cyclin-dependent kinases or other regulators of cell cycling. Future studies will be required to comprehensively identify novel scleraxis gene targets as well as the mechanism by which such regulation may occur.
Our findings thus demonstrate that scleraxis is transcriptionally activated by stretch and in turn regulates the major characteristics of the myofibroblast phenotype: induction of collagen synthesis; formation of focal adhesions and stress fibers; reduction of migration; and decreased proliferation with cell cycle exit. Together, this work provides strong evidence that scleraxis is a novel regulator of the cardiac myofibroblast phenotype and paves the way for further studies examining the potential for scleraxis as a highly specific therapeutic target for the reversal of the myofibroblast phenotype and attenuation of cardiac fibrosis in vivo.
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We thank Dr. Christine Zhang for assistance with flow cytometry; Drs. Grant Pierce, Todd Duhamel, and Ian Dixon for technical facilities; and Hamza Fig. 6 . Scleraxis reduces cardiac proto-myofibroblast proliferation. A: freshly isolated cardiac fibroblasts (P0), proto-myofibroblasts (P1), or myofibroblasts (P2) were stained with propidium iodide and assessed for cell cycle phase by flow cytometry. B: cell cycle data from A was normalized to total counted cells. C: cardiac proto-myofibroblasts infected with adenovirus encoding GFP (AdGFP) or scleraxis (AdScx) were stained with EdU to assess cell proliferation; red stain marks EdU ϩ proliferating cells, blue stain (Hoechst 33342) marks all cell nuclei; magnification: ϫ200; scale bar ϭ 50 m. D: results from the experiment depicted in C were quantified; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. AdGFP. E: AdGFP-or AdScx-infected cardiac proto-myofibroblasts were assessed for cell cycle as in A. F: cell cycle data from E was normalized to total counted cells. G: cardiac fibroblasts (P0), proto-myofibroblasts (P1), or myofibroblasts (P2) were assessed for PCNA expression by Western blot. Results were normalized to ␣-tubulin and P0; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. P0; #P Ͻ 0.05 vs. P1. H: cardiac proto-myofibroblasts subjected to 15% equibiaxial stretch (1 Hz) for 24 h or unstretched controls were assessed for PCNA expression. Results were normalized to ␣-tubulin and unstretched controls; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. control. Note: the loading control shown in H is the same as in Fig. 5F as the blot was reprobed. I: AdGFP-or AdScx-infected cardiac proto-myofibroblasts were assayed for PCNA expression. Results were normalized to ␣-tubulin and AdGFP; mean Ϯ SE; n ϭ 3; *P Ͻ 0.05 vs. control. In turn, scleraxis is required for and activates the fibroblast to myofibroblast phenotype conversion program, whose hallmarks include increased fibrosis (via direct transcriptional control of collagen gene expression) and cell contraction (via direct transcriptional control of ␣-SMA expression) (3). Myofibroblasts also exhibit decreased migration due to increased cell adhesion via increased expression of focal adhesion components vinculin, integrin-␤1 (Itg␤1) and F-actin and reduced FAK phosphorylation at Y397, as well as decreased proliferation via an unknown mediator.
